Skip to main content

GOLDMAN SACHS GROUP INC

Position in FLNA — Filana Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in FLNA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$69,837
+$4,519 QoQ
Shares Held
41,324
+25.3% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLNA Over Time

Shares Held

Position Value (USD)

Derivatives in FLNA

reported options exposure · as of Jun 30, 2024
CallValue
$0
CallShares
0
PutValue
$219,830
PutShares
17,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. FLNA ranks #344 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLNA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $69,837 41,324
2025-12-31 $65,318 32,989
2025-09-30 $1,376,022 472,860
2025-06-30 $1,109,788 613,143
2025-03-31 $744,469 496,313
2024-12-31 $658,225 278,909
2024-09-30 $4,500,994 152,939
2024-06-30 $219,830 17,800
2024-06-30 $1,052,775 85,245
2024-03-31 $1,071,940 52,831
2023-12-31 $3,638,943 161,659
2023-09-30 $885,297 53,203
2023-06-30 $1,606,550 65,520
2023-03-31 $1,531,933 63,513
2022-12-31 $4,704,155 159,247
2022-09-30 $3,211,566 76,795
2022-06-30 $1,056,102 37,557
2022-03-31 $1,455,739 39,196
2021-12-31 $2,399,697 54,913
2021-09-30 $3,225,490 51,957
2021-06-30 $5,566,586 65,152
2021-03-31 $2,171,714 48,314
2020-12-31 $132,635 19,448
2020-09-30 $144,369 12,543